phase readout
saveNCT01711554: Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
ACTIVE_NOT_RECRUITINGupdated 16d ago
community read0 votes
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Recurrent Neuroblastoma, Refractory Neuroblastoma
view source ↗
comments(0)
5-min edit window · permanent after that